Literature DB >> 17712471

Community-onset candidemia at a university hospital, 1995-2005.

Hsiang-Chi Kung1, Jiun-Ling Wang, Shan-Chwen Chang, Jann-Tay Wang, Hsin-Yun Sun, Po-Ren Hsueh, Yee-Chun Chen.   

Abstract

BACKGROUND AND
PURPOSE: Although not all candidemias are hospital-acquired, data on clinical epidemiology for the community-onset candidemia are limited. This retrospective study was conducted to describe predisposing factors and outcomes of community-onset candidemias.
METHODS: Medical records of patients who were admitted to the National Taiwan University Hospital between January 1, 1995 and May 31, 2005 and had Candida isolated from their blood in the outpatient setting and/or within 48 h of hospitalization (community-onset) were reviewed.
RESULTS: A total of 56 episodes of candidemia were reviewed, which included 8 episodes (14.3%) of true community-acquired candidemia occurring in patients with no record of hospitalization within the previous 30 days and without histories of invasive procedures either just before or at the time of admission, and 48 episodes (85.7%) that were health care-associated. The latter included 24 episodes (42.9%) in patients recently discharged from hospitals (within 2-30 days of current admission), 23 episodes (41.1%) associated with invasive procedures and/or central intravascular lines placed for outpatient therapy, and 1 episode (1.8%) in patients admitted from nursing homes. Gastrointestinal bleeding (46.4%), immunosuppressive therapy (42.9%) and previous antibiotics use (37.5%) were the most common predisposing factors. Diabetes was the single most important predisposing factor in true community-acquired candidemia (62.5%) and had a significantly higher prevalence among these patients than in those with health care-associated candidemias (p=0.035). Candida albicans was the most common isolate (39.7%), followed by Candida tropicalis (22.4%) and Candida glabrata (17.2%). The overall case fatality rate was 55.4% (31/56), and 58.1% (18/31) of this was attributable to candidemia. Multivariate analysis identified higher severity score and lack of antifungal therapy as having an independent and adverse influence on outcome.
CONCLUSIONS: Up to 85.7% of community-onset candidemias are health care-associated. There is a conceptual and practical need for a new classification for the spectrum of acquisition of infection, wherein the new category of health care-associated infection will have implications for the selection of empirical therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17712471

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  8 in total

1.  Molecular identification of closely related Candida species using two ribosomal intergenic spacer fingerprinting methods.

Authors:  Muriel Cornet; Boualem Sendid; Chantal Fradin; Claude Gaillardin; Daniel Poulain; Huu-Vang Nguyen
Journal:  J Mol Diagn       Date:  2010-12-23       Impact factor: 5.568

2.  Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.

Authors:  Michael A Pfaller; Gary J Moet; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

3.  Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections.

Authors:  A V Ferreira; C G Prado; R R Carvalho; K S T Dias; A L T Dias
Journal:  Mycopathologia       Date:  2013-03-27       Impact factor: 2.574

4.  Mortality in patients with early- or late-onset candidaemia.

Authors:  Francesco Giuseppe De Rosa; Enrico Maria Trecarichi; Chiara Montrucchio; Angela Raffaella Losito; Stefania Raviolo; Brunella Posteraro; Silvia Corcione; Simona Di Giambenedetto; Lucina Fossati; Maurizio Sanguinetti; Roberto Serra; Roberto Cauda; Giovanni Di Perri; Mario Tumbarello
Journal:  J Antimicrob Chemother       Date:  2012-12-12       Impact factor: 5.790

5.  An observational study on the epidemiological and mycological profile of Candidemia in ICU patients.

Authors:  Aarti Kotwal; Debasis Biswas; Jagdish Prasad Sharma; Alpa Gupta; Parul Jindal
Journal:  Med Sci Monit       Date:  2011-11

Review 6.  Diabetes and sepsis: preclinical findings and clinical relevance.

Authors:  Philipp Schuetz; Pedro Castro; Nathan I Shapiro
Journal:  Diabetes Care       Date:  2011-03       Impact factor: 19.112

7.  Fungal Diseases in Taiwan-National Insurance Data and Estimation.

Authors:  Yu-Shan Huang; David W Denning; Shu-Man Shih; Chao A Hsiung; Un-In Wu; Hsin-Yun Sun; Pao-Yu Chen; Yee-Chun Chen; Shan-Chwen Chang
Journal:  J Fungi (Basel)       Date:  2019-08-21

8.  The value of a risk model for early-onset candidemia.

Authors:  Christian Sandrock; Javeed Siddiqui
Journal:  Crit Care       Date:  2009-11-16       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.